#neoadjuvant — Thursday, April 02, 2026 (1 items)
| 0 | 💬 0 |
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer.
(nejm.org)
|
New England Journal of Medicine 2026-04-02 | #cancer #clinical trial #immunotherapy #neoadjuvant |